Nextcell is a technology company that specializes in the development and manufacturing of advanced cellular therapy products. They aim to revolutionize healthcare by providing innovative solutions for the treatment of various diseases and medical conditions.
Nextcell was founded in 2017 with a vision to transform healthcare through cellular therapy.
The company is headquartered in Stockholm, Sweden.
Nextcell's team of scientists and researchers have extensive experience in the field of regenerative medicine.
In 2018, Nextcell received funding to support the development of their flagship product, ProTrans, a treatment for type 1 diabetes.
Nextcell has collaborated with leading institutions and universities to advance their research and product development.
The company has obtained patents for their cell manufacturing technology and continues to innovate in the field of cellular therapy.
Novartis is a multinational pharmaceutical company that also focuses on the development of cell-based therapeutics. They have a strong presence in the medical industry and a wide range of products.
Kite Pharma is a biopharmaceutical company that specializes in the development of cell therapy products for the treatment of cancer. They are known for their groundbreaking CAR-T therapies.
Bluebird Bio is a gene therapy company that aims to develop transformative gene-based medicines for severe genetic diseases and cancer. They have a diverse pipeline of products in various stages of development.
ProTrans is Nextcell's flagship product, designed for the treatment of type 1 diabetes. It involves the transplantation of insulin-producing cells to restore normal blood sugar regulation.
CellExpansion is a technology developed by Nextcell that enables the efficient production of therapeutic cells for various applications. It allows for the expansion of desired cell populations for transplantation.
CellStorage is a state-of-the-art cryopreservation system developed by Nextcell. It ensures the long-term storage and viability of therapeutic cells for later use.
Cellular therapy refers to the use of cells, typically stem cells or immune cells, to treat diseases or medical conditions. It involves the transplantation or modification of cells to restore or enhance the normal functioning of the body.
ProTrans works by transplanting insulin-producing cells into the body of a person with type 1 diabetes. These cells then help regulate blood sugar levels by producing insulin, which the person's body is unable to produce on its own.
Nextcell follows stringent manufacturing and quality control processes to ensure the safety of their cellular therapy products. Extensive research and clinical trials are conducted to evaluate the safety and efficacy of their treatments.
Cellular therapy has the potential to treat a wide range of diseases, including cancer, diabetes, neurodegenerative disorders, cardiovascular diseases, and genetic disorders. The specific application depends on the type of cells and their therapeutic properties.
Yes, Nextcell's research and product development are driven by scientific evidence. They collaborate with renowned institutions and universities, conduct clinical trials, and publish their findings in peer-reviewed journals.